Axol Bioscience cardiomyocytes are derived from human iPSCs.
Human iPSC-derived Atrial Cardiomyocytes (1 million cells per vial)
Click to use our product calculator.
From: $494.00
Axol Bioscience cardiomyocytes are derived from human iPSCs.
Human iPSC-derived Atrial Cardiomyocytes (1 million cells per vial)
Axol iPSC-Derived Atrial Cardiomyocytes express atrial specific markers atrial myosin light chain 2 (MLC2a) and atrial natriuretic peptide (ANP). Atrial cardiomyocytes are key for the study of atrial fibrillation such as irregular heart rate making them excellent for disease modelling.
Our iPSC-derived Atrial Cardiomyocytes have been derived from the same 74 year old male donor as our highly-validated iPSC-Derived Ventricular Cardiomyocytes. Axol iPSC-derived cardiomyocytes and fully-defined, serum-free Cardiomyocyte Maintenance Medium offers researchers a complete portfolio of complementary cell types and culture reagents for disease modelling and cardiotoxicity testing.
Starting material | Fibroblasts |
Donor gender | Male |
Donor age at sampling | 74 yrs |
Reprogramming method | Episomal vector |
Induction method | Fully defined medium |
Size | 1 million cells |
Growth properties | Adherent |
Disease information | Healthy |
Shipping conditions | Dry ice |
Storage conditions | vapour phase nitrogen |